Table 3.
Reagents | Animal Strains | Disease Models | Culture Cells | Upstream of AMPK | Downstream of AMPK | Intracellular Effects | Cellular Effects | CVDs and Complications | Refs |
---|---|---|---|---|---|---|---|---|---|
Berberine | APOE−/− mice, APOE−/−/AMPKα2−/− mice | WD | HUVEC | Mitochondrial ROS | NRF1-UCP2 axis | Oxidative stress | Endothelial dysfunction | Atherosclerosis | [128] |
Fucoxanthin | N/A | oxLDL | HUVEC | N/A | PKC-NOX-AKT-CREB-PGC1α axis | Oxidative stress; Mitochondrial dysfunction |
Endothelial dysfunction | Atherosclerosis | [129] |
Salidroside | LDLR−/− mice | HFD | HUVEC | AMP-to-ATP ratio | PI3K/AKT-eNOS-NO axis | NO bioavailability | Endothelial dysfunction | Atherosclerosis | [130] |
Mitochondria-targeted esculetin | APOE−/− mice | AngII | HAEC | Mitochondrial ROS | eNOS-NO-SIRT3-TFAM/PGC1α axis | Mitochondrial biogenesis | Endothelial dysfunction | Atherosclerosis | [131] |
N/A | AMPKα1−/− mice, AMPKα2−/− mice | N/A | HUVEC, MAEC, PMEC | Mitochondrial ROS | UCP2 | Oxidative stress | Angiogenesis | Ischemia | [132] |
eNOS-NO axis | NO bioavailability | ||||||||
N/A | N/A | H9c2 | Mitochondrial ROS | N/A | Mitophagy | Cardioprotection | Ischemia | [133] | |
Melatonin | AMPKα−/− mice | N/A | CMEC | N/A | DRP1-VDAC1/HK2/MPTP-PINK1/PARKIN axis | Mitophagy | Cell death | Ischemia /reperfusion |
[134] |
Nitrite | WT mice | N/A | H9c2 | PKA-DRP1-mitochondrial ROS axis | N/A | Mitochondrial fission | Cell death | Ischemia /reperfusion |
[135] |
The mitochondrial open reading frame of the 12S rRNA-c | WT mice | Vitamin D3, Nicotine | N/A | N/A | ETB and AT1 | N/A | N/A | Vascular calcification | [136] |
The translocator protein | WT mice | Balloon injury model, PDGF-BB | A10 | N/A | N/A | N/A | VSMC proliferation and migration | Neointima formation | [137] |
N/A | SIRT5−/− mice | TAC model | HEK293T | SIRT5-AMP/ATP axis | N/A | N/A | Cardiac dysfunction | Cardiac hypertrophy | [138] |
N/A | AMPKα2−/− mice | TAC model | HEK293T | N/A | PINK1/PARKIN axis | Mitophagy | Cardiac dysfunction | Cardiac hypertrophy | [117] |
N/A | AMPKα2−/− mice | STZ | H9c2, Cardiomyocyte |
N/A | FUNDC1-MAMs axis | Mitochondrial dysfunction | Cardiomyopathy | Diabetes | [139] |
Melatonin | N/A | LPS | HUVEC | N/A | SERCA2a-Calcium-XO-ROS-DRP1 axis | Mitochondrial fission | Cell apoptosis | Inflammation | [140] |
Corosolic acid | WT mice | PA | RAEC, HUVEC | LKB1 | DRP1-NOX2-ROS-NLRP3 axis | Mitochondrial fission; Oxidative stress; Inflammation |
Cell death | Obesity | [141] |
Punicalagin | WT mice | HFD | Cardiomyocyte | ADP-to-ATP ratio | PGC1α | Mitochondrial biogenesis | Cardiac dysfunction | obesity | [142] |
NRF2-Phase II enzyme | Oxidative stress |